JP2016500653A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016500653A5 JP2016500653A5 JP2015533704A JP2015533704A JP2016500653A5 JP 2016500653 A5 JP2016500653 A5 JP 2016500653A5 JP 2015533704 A JP2015533704 A JP 2015533704A JP 2015533704 A JP2015533704 A JP 2015533704A JP 2016500653 A5 JP2016500653 A5 JP 2016500653A5
- Authority
- JP
- Japan
- Prior art keywords
- meleu
- leu
- methyl
- methylamino
- meval
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 32
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 32
- 150000001875 compounds Chemical class 0.000 claims 20
- -1 NH 2 Chemical group 0.000 claims 17
- 125000000217 alkyl group Chemical group 0.000 claims 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims 15
- 125000000547 substituted alkyl group Chemical group 0.000 claims 14
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- 125000003107 substituted aryl group Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 5
- 125000004414 alkyl thio group Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 150000001204 N-oxides Chemical class 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 150000002466 imines Chemical class 0.000 claims 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 2
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 claims 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 1
- KXZQYLBVMZGIKC-UHFFFAOYSA-N 1-pyridin-2-yl-n-(pyridin-2-ylmethyl)methanamine Chemical compound C=1C=CC=NC=1CNCC1=CC=CC=N1 KXZQYLBVMZGIKC-UHFFFAOYSA-N 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- UNIJBMUBHBAUET-UHFFFAOYSA-N 3-(methylamino)propanenitrile Chemical compound CNCCC#N UNIJBMUBHBAUET-UHFFFAOYSA-N 0.000 claims 1
- MJOUJKDTBGXKIU-UHFFFAOYSA-N 4,4-difluoropiperidine Chemical compound FC1(F)CCNCC1 MJOUJKDTBGXKIU-UHFFFAOYSA-N 0.000 claims 1
- POOPWPIOIMBTOH-UHFFFAOYSA-N 8-oxa-3-azabicyclo[3.2.1]octane Chemical compound C1NCC2CCC1O2 POOPWPIOIMBTOH-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- SVEUVITYHIHZQE-UHFFFAOYSA-N n-methylpyridin-2-amine Chemical compound CNC1=CC=CC=N1 SVEUVITYHIHZQE-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- CCHDRLLWDRWYAN-QMMMGPOBSA-N CC(C)C[C@@H](C(C)=O)N=C Chemical compound CC(C)C[C@@H](C(C)=O)N=C CCHDRLLWDRWYAN-QMMMGPOBSA-N 0.000 description 1
- 0 CC(C)C[C@@](C(C)=*)NC Chemical compound CC(C)C[C@@](C(C)=*)NC 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1217560.0 | 2012-10-02 | ||
| GBGB1217560.0A GB201217560D0 (en) | 2012-10-02 | 2012-10-02 | Novel cyclic depsipeptide compounds and their uses |
| PCT/GB2013/052570 WO2014053834A1 (en) | 2012-10-02 | 2013-10-02 | Cyclic depsipeptide compounds and their uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016500653A JP2016500653A (ja) | 2016-01-14 |
| JP2016500653A5 true JP2016500653A5 (OSRAM) | 2016-10-06 |
| JP6263541B2 JP6263541B2 (ja) | 2018-01-17 |
Family
ID=47225510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015533704A Expired - Fee Related JP6263541B2 (ja) | 2012-10-02 | 2013-10-02 | 環状デプシペプチド化合物およびそれらの用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9382295B2 (OSRAM) |
| EP (1) | EP2904001A1 (OSRAM) |
| JP (1) | JP6263541B2 (OSRAM) |
| CN (1) | CN104768968B (OSRAM) |
| AU (1) | AU2013326231B2 (OSRAM) |
| CA (1) | CA2885940A1 (OSRAM) |
| GB (1) | GB201217560D0 (OSRAM) |
| WO (1) | WO2014053834A1 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016112321A1 (en) * | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| WO2017181179A1 (en) * | 2016-04-15 | 2017-10-19 | The Regents Of The University Of California | Antimicrobial compositions |
| CN111449050A (zh) | 2019-01-20 | 2020-07-28 | 睿诺医疗科技（上海）有限公司 | 环孢菌素类似物及其用途 |
| CN109821020B (zh) * | 2019-01-28 | 2021-07-30 | 温州医科大学 | 一种制备干眼症药物的应用及治疗干眼症的方法 |
| CN114401733A (zh) | 2019-10-12 | 2022-04-26 | 睿诺医疗科技（上海）有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| BR112022007535A2 (pt) * | 2019-11-07 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Composto peptídico cíclico tendo ação inibitória de kras |
| KR20220158761A (ko) | 2020-03-26 | 2022-12-01 | 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 | 사이클로스포린 유도체의 제조 |
| EP4135743A4 (en) | 2020-04-15 | 2024-05-22 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3851268T2 (de) * | 1987-06-19 | 1995-01-26 | Sandoz Ag | Zyklische Peptolide. |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| US8889629B2 (en) | 2005-01-10 | 2014-11-18 | Debiopharm International Sa | Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events |
| NZ593204A (en) * | 2008-11-06 | 2013-02-22 | Debio Rech Pharma Sa | Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
| WO2011141891A1 (en) | 2010-05-12 | 2011-11-17 | Debio Recherche Pharmaceutique S.A. | Use of cycloundecadepsipeptide compounds |
-
2012
- 2012-10-02 GB GBGB1217560.0A patent/GB201217560D0/en not_active Ceased
-
2013
- 2013-10-02 EP EP13771583.5A patent/EP2904001A1/en not_active Withdrawn
- 2013-10-02 US US14/433,327 patent/US9382295B2/en not_active Expired - Fee Related
- 2013-10-02 WO PCT/GB2013/052570 patent/WO2014053834A1/en not_active Ceased
- 2013-10-02 JP JP2015533704A patent/JP6263541B2/ja not_active Expired - Fee Related
- 2013-10-02 CA CA2885940A patent/CA2885940A1/en not_active Abandoned
- 2013-10-02 CN CN201380056072.1A patent/CN104768968B/zh not_active Expired - Fee Related
- 2013-10-02 AU AU2013326231A patent/AU2013326231B2/en not_active Ceased
-
2016
- 2016-06-20 US US15/187,039 patent/US9895412B2/en active Active
-
2018
- 2018-01-29 US US15/882,510 patent/US20180153958A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016500653A5 (OSRAM) | ||
| AR059622A1 (es) | Quinolonas utiles como inhibidores de la sintetasa del oxido nitrico inducibles | |
| JP2013530176A5 (OSRAM) | ||
| JP2018537413A5 (ja) | 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物 | |
| JP2012140432A5 (OSRAM) | ||
| JP2013537203A5 (OSRAM) | ||
| ES2640911T3 (es) | Cicloalquilnitrilpirazolcarboxamidas como inhibidores de la quinasa Janus | |
| JP2019513778A5 (OSRAM) | ||
| WO2011004162A3 (en) | 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer | |
| JP2012523457A5 (OSRAM) | ||
| HUP0401784A2 (hu) | Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények | |
| WO2010089510A3 (fr) | Dérivés d'azaspiranyl-alkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique | |
| AR081587A1 (es) | DERIVADOS DE 5,6-DIHIDRO-2H-[1,4]OXAZIN-3-IL-AMINA UTILES COMO INHIBIDORES DE LA b-SECRETASA (BACE) | |
| JP2011219498A5 (OSRAM) | ||
| JP2013509392A5 (OSRAM) | ||
| AR057915A1 (es) | Compuesto con estructura de cinamida de dos ciclos con actividad inhibitoria de la produccion de abeta40 y abeta42, un agente farmaceutico que lo comprende y el uso de este en el tratamiento de enfermedades mentales y neurodegenerativas. | |
| RU2017123114A (ru) | 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов | |
| MX2013004407A (es) | Derivado de piridina y agente medicinal. | |
| SMT201300085B (it) | Composti di pirrolo | |
| AR085615A1 (es) | Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen | |
| MX2009008509A (es) | Compuesto de anillo puenteado-aza. | |
| JP2015504081A5 (OSRAM) | ||
| ECSP13012812A (es) | Formulaciones inmunosupresoras | |
| WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
| DK2868660T3 (da) | Anti-tumoreffekt-potentiator omfattende en imidazooxazin-forbindelse |